Psychopharmacology

, Volume 188, Issue 4, pp 425–444 | Cite as

The acute effects of cannabinoids on memory in humans: a review

Review

Abstract

Rationale

Cannabis is one of the most frequently used substances. Cannabis and its constituent cannabinoids are known to impair several aspects of cognitive function, with the most robust effects on short-term episodic and working memory in humans. A large body of the work in this area occurred in the 1970s before the discovery of cannabinoid receptors. Recent advances in the knowledge of cannabinoid receptors’ function have rekindled interest in examining effects of exogenous cannabinoids on memory and in understanding the mechanism of these effects.

Objective

The literature about the acute effects of cannabinoids on memory tasks in humans is reviewed. The limitations of the human literature including issues of dose, route of administration, small sample sizes, sample selection, effects of other drug use, tolerance and dependence to cannabinoids, and the timing and sensitivity of psychological tests are discussed. Finally, the human literature is discussed against the backdrop of preclinical findings.

Results

Acute administration of Δ-9-THC transiently impairs immediate and delayed free recall of information presented after, but not before, drug administration in a dose- and delay-dependent manner. In particular, cannabinoids increase intrusion errors. These effects are more robust with the inhaled and intravenous route and correspond to peak drug levels.

Conclusions

This profile of effects suggests that cannabinoids impair all stages of memory including encoding, consolidation, and retrieval. Several mechanisms, including effects on long-term potentiation and long-term depression and the inhibition of neurotransmitter (GABA, glutamate, acetyl choline, dopamine) release, have been implicated in the amnestic effects of cannabinoids. Future research in humans is necessary to characterize the neuroanatomical and neurochemical basis of the memory impairing effects of cannabinoids, to dissect out their effects on the various stages of memory and to bridge the expanding gap between the humans and preclinical literature.

Keywords

Cannabinoids Cannabis Marijuana Δ-9-THC Memory Learning Cognition 

Abbreviations

CB

cannabinoid

CB1

cannabinoid 1 receptor

Δ-9-THC

delta-9-tetrahydrocannabinol

CBD

cannabidiol

References

  1. Abel EL (1971) Marihuana and memory: acquisition or retrieval? Science 173:1038–1040PubMedGoogle Scholar
  2. Abel T, Lattal KM (2001) Molecular mechanisms of memory acquisition, consolidation and retrieval. Curr Opin Neurobiol 11:180–187PubMedGoogle Scholar
  3. Acquas E, Pisanu A, Marrocu P, Di Chiara G (2000) Cannabinoid CB(1) receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo. Eur J Pharmacol 401:179–185PubMedGoogle Scholar
  4. Acquas E, Pisanu A, Marrocu P, Goldberg SR, Di Chiara G (2001) Delta9-tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo: a microdialysis study. Eur J Pharmacol 419:155–161PubMedGoogle Scholar
  5. Adams IB, Martin BR (1996) Cannabis: pharmacology and toxicology in animals and humans. Addiction 91:1585–1614PubMedGoogle Scholar
  6. Agurell S, Halldin M, Lindgren JE, Ohlsson A, Widman M, Gillespie H, Hollister L (1986) Pharmacokinetics and metabolism of delta 9-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol Rev 38:21–43PubMedGoogle Scholar
  7. Aigner TG (1988) Delta-9-tetrahydrocannabinol impairs visual recognition memory but not discrimination learning in rhesus monkeys. Psychopharmacology (Berl) 95:507–511Google Scholar
  8. Atkinson R, Shiffrin RM (1968) Human memory: a proposed system and its control processes. New York Academic Press, New YorkGoogle Scholar
  9. Baddeley A (1999) Essentials of human memory. Psychology PressGoogle Scholar
  10. Baddeley A, Chincotta D, Adlam A (2001) Working memory and the control of action: evidence from task switching. J Exp Psychol Gen 130:641–657PubMedGoogle Scholar
  11. Baker D, Pryce G, Davies WL, Hiley CR (2006) In silico patent searching reveals a new cannabinoid receptor. Trends Pharmacol Sci 27:1–4PubMedGoogle Scholar
  12. Belmore SM, Miller LL (1980) Levels of processing and acute effects of marijuana on memory. Pharmacol Biochem Behav 13:199–203PubMedGoogle Scholar
  13. Block RI, Farinpour R, Braverman K (1992) Acute effects of marijuana on cognition: relationships to chronic effects and smoking techniques. Pharmacol Biochem Behav 43:907–917PubMedGoogle Scholar
  14. Bohme GA, Laville M, Ledent C, Parmentier M, Imperato A (2000) Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors. Neuroscience 95:5–7PubMedGoogle Scholar
  15. Brodkin J, Moerschbaecher JM (1997) SR141716A antagonizes the disruptive effects of cannabinoid ligands on learning in rats. J Pharmacol Exp Ther 282:1526–1532PubMedGoogle Scholar
  16. Budney AJ, Moore BA, Vandrey RG, Hughes JR (2003) The time course and significance of cannabis withdrawal. J Abnorm Psychology 112:393–402Google Scholar
  17. Budney AJ, Hughes JR, Moore BA, Vandrey R (2004) Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry 161:1967–1977PubMedGoogle Scholar
  18. Buschke H, Fuld PA (1974) Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 24:1019–1025PubMedGoogle Scholar
  19. Carlini EA, Hamaoui A, Bieniek D, Korte F (1970a) Effects of (−) delta-9-trans-tetrahydrocannabinol and a synthetic derivative on maze performance of rats. Pharmacology 4:359–368PubMedGoogle Scholar
  20. Carlini EA, Santos M, Claussen U, Bieniek D, Korte F (1970b) Structure activity relationship of four tetrahydrocannabinols and the pharmacological activity of five semi-purified extracts of Cannabis sativa. Psychopharmacologia 18:82–93PubMedGoogle Scholar
  21. Castellano C, Rossi-Arnaud C, Cestari V, Costanzi M (2003) Cannabinoids and memory: animal studies. Curr Drug Targets CNS Neurol Disord 2:389–402PubMedGoogle Scholar
  22. Chait LD, Perry JL (1994) Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performance. Psychopharmacology (Berl) 115:340–349Google Scholar
  23. Chait LD, Zacny JP (1992) Reinforcing and subjective effects of oral delta 9-THC and smoked marijuana in humans. Psychopharmacology 107:255–262Google Scholar
  24. Chen J, Paredes W, Lowinson JH, Gardner EL (1990) Delta 9-tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex. Eur J Pharmacol 190:259–262PubMedGoogle Scholar
  25. Collins DR, Pertwee RG, Davies SN (1994) The action of synthetic cannabinoids on the induction of long-term potentiation in the rat hippocampal slice. Eur J Pharmacol 259:R7–R8PubMedGoogle Scholar
  26. Compton DR, Johnson MR, Melvin LS, Martin BR (1992) Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents. J Pharmacol Exp Ther 260:201–209PubMedGoogle Scholar
  27. Curran HV, Brignell C, Fletcher S, Middleton P, Henry J (2002) Cognitive and subjective dose–response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology (Berl) 164:61–70Google Scholar
  28. Da Silva GE, Takahashi RN (2002) SR 141716A prevents delta 9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice. Prog neuropsychopharmacol Biol Psychiatry 26:321–325Google Scholar
  29. Darley CF, Tinklenberg JR, Hollister TE, Atkinson RC (1973) Marihuana and retrieval from short-term memory. Psychopharmacologia 29:231–238PubMedGoogle Scholar
  30. Darley CF, Tinklenberg JR, Roth WT, Atkinson RC (1974) The nature of storage deficits and state-dependent retrieval under marihuana. Psychopharmacologia 37:139–149PubMedGoogle Scholar
  31. Davies SN, Pertwee RG, Riedel G (2002) Functions of cannabinoid receptors in the hippocampus. Neuropharmacology 42:993–1007PubMedGoogle Scholar
  32. de Oliveira Alvares L, de Oliveira LF, Camboim C, Diehl F, Genro BP, Lanziotti VB, Quillfeldt JA (2005) Amnestic effect of intrahippocampal AM251, a CB1-selective blocker, in the inhibitory avoidance, but not in the open field habituation task, in rats. Neurobiol Learn Mem 83:119–124PubMedGoogle Scholar
  33. Demuth DG, Molleman A (2005) Cannabinoid signalling. Life Sci 78:549–563PubMedGoogle Scholar
  34. Dhawan J, Deng H, Gatley SJ, Makriyannis A, Akinfeleye T, Bruneus M, Dimaio AA, Gifford AN (2006) Evaluation of the in vivo receptor occupancy for the behavioral effects of cannabinoids using a radiolabeled cannabinoid receptor agonist, R-[(125/131)I]AM2233. Synapse 60:93–101PubMedGoogle Scholar
  35. Diana M, Melis M, Gessa GL (1998) Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids. Eur J Neurosci 10:2825–2830PubMedGoogle Scholar
  36. D’Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, Braley G, Gueorguieva R, Krystal JH (2004) The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 29:1558–1572PubMedGoogle Scholar
  37. D’Souza DC, Abi-Saab WM, Madonick S, Forselius-Bielen K, Doersch A, Braley G, Gueorguieva R, Cooper TB, Krystal JH (2005) Delta-9-tetrahydrocannabinol effects in schizophrenia:implications for cognition, psychosis, and addiction. Biol Psychiatry 57:594–608PubMedGoogle Scholar
  38. Dudai Y (2004) The neurobiology of consolidations, or, how stable is the engram? Annu Rev Psychol 55:51–86PubMedGoogle Scholar
  39. Dudai Y, Eisenberg M (2004) Rites of passage of the engram: reconsolidation and the lingering consolidation hypothesis. Neuron 44:93–100PubMedGoogle Scholar
  40. Fant RV, Heishman SJ, Bunker EB, Pickworth WB (1998) Acute and residual effects of marijuana in humans. Pharmacol Biochem Behav 60:777–784PubMedGoogle Scholar
  41. Ferraro DP (1980) Acute effects of marijuana on human memory and cognition. NIDA Res Monogr 31:98–119PubMedGoogle Scholar
  42. Ferraro DP, Grilly DM (1974) Effects of chronic exposure to delta9-tetrahydrocannabinol on delayed matching-to-sample in chimpanzees. Psychopharmacologia 37:127–138PubMedGoogle Scholar
  43. Fletcher PC, Henson RN (2001) Frontal lobes and human memory: insights from functional neuroimaging. Brain 124:849–881PubMedGoogle Scholar
  44. Freedland CS, Whitlow CT, Miller MD, Porrino LJ (2002) Dose-dependent effects of Delta9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat. Synapse 45:134–142PubMedGoogle Scholar
  45. Gerard CM, Mollereau C, Vassart G, Parmentier M (1991) Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem J 279:129–134PubMedGoogle Scholar
  46. Gessa GL, Mascia MS, Casu MA, Carta G (1997) Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A. Eur J Pharmacol 327:R1–R2PubMedGoogle Scholar
  47. Gessa GL, Casu MA, Carta G, Mascia MS (1998) Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR 141716A. Eur J Pharmacol 355:119–124PubMedGoogle Scholar
  48. Greenwald MK, Stitzer ML (2000) Antinociceptive, subjective and behavioral effects of smoked marijuana in humans. Drug Alcohol Depend 59:261–275PubMedGoogle Scholar
  49. Grotenhermen F (2003) Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet 42:327–360PubMedGoogle Scholar
  50. Hajos N, Katona I, Naiem SS, MacKie K, Ledent C, Mody I, Freund TF (2000) Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci 12:3239–3249PubMedGoogle Scholar
  51. Hajos N, Ledent C, Freund TF (2001) Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106:1–4PubMedGoogle Scholar
  52. Hampson RE, Simeral JD, Kelly EJ, Deadwyler SA (2003) Tolerance to the memory disruptive effects of cannabinoids involves adaptation by hippocampal neurons. Hippocampus 13:543–556PubMedGoogle Scholar
  53. Hart CL, van Gorp W, Haney M, Foltin RW, Fischman MW (2001) Effects of acute smoked marijuana on complex cognitive performance. Neuropsychopharmacology 25:757–765PubMedGoogle Scholar
  54. Heishman SJ, Huestis MA, Henningfield JE, Cone EJ (1990) Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures. Pharmacol Biochem Behav 37:561–565PubMedGoogle Scholar
  55. Heishman SJ, Arasteh K, Stitzer ML (1997) Comparative effects of alcohol and marijuana on mood, memory, and performance. Pharmacol Biochem Behav 58:93–101PubMedGoogle Scholar
  56. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A 87:1932–1936PubMedGoogle Scholar
  57. Heyser CJ, Hampson RE, Deadwyler SA (1993) Effects of delta-9-tetrahydrocannabinol on delayed match to sample performance in rats: alterations in short-term memory associated with changes in task specific firing of hippocampal cells. J Pharmacol Exp Ther 264:294–307PubMedGoogle Scholar
  58. Hoffman AF, Lupica CR (2000) Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. J Neurosci 20:2470–2479PubMedGoogle Scholar
  59. Hollister LE, Gillespie HK, Ohlsson A, Lindgren JE, Wahlen A, Agurell S (1981) Do plasma concentrations of delta 9-tetrahydrocannabinol reflect the degree of intoxication? J Clin Pharmacol 21:171S–177SPubMedGoogle Scholar
  60. Hooker WD, Jones RT (1987) Increased susceptibility to memory intrusions and the Stroop interference effect during acute marijuana intoxication. Psychopharmacology (Berl) 91:20–24Google Scholar
  61. Howlett AC (2004) Efficacy in CB1 receptor-mediated signal transduction. Br J Pharmacol 142:1209–1218PubMedGoogle Scholar
  62. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161–202PubMedGoogle Scholar
  63. Ilan AB, Smith ME, Gevins A (2004) Effects of marijuana on neurophysiological signals of working and episodic memory. Psychopharmacology (Berl) 176:214–222Google Scholar
  64. Iversen L (2003) Comparing cannabis with tobacco: arithmetic does not add up (comment). BMJ 327:165PubMedGoogle Scholar
  65. Iversen L (2005) Long-term effects of exposure to cannabis. Curr Opin Pharmacol 5:69–72PubMedGoogle Scholar
  66. Jentsch JD, Verrico CD, Le D, Roth RH (1998) Repeated exposure to delta 9-tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the rat. Neurosci Lett 246:169–172PubMedGoogle Scholar
  67. Johansson E, Agurell S, Hollister LE, Halldin MM (1988) Prolonged apparent half-life of delta 1-tetrahydrocannabinol in plasma of chronic marijuana users. J Pharm Pharmacol 40:374–375PubMedGoogle Scholar
  68. Kanayama G, Rogowska J, Pope HG, Gruber SA, Yurgelun-Todd DA (2004) Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study. Psychopharmacology (Berl) 176:239–247Google Scholar
  69. Karniol IG, Carlini EA (1973) Pharmacological interaction between cannabidiol and delta 9-tetrahydrocannabinol. Psychopharmacologia 33:53–70PubMedGoogle Scholar
  70. Karniol IG, Shirakawa I, Kasinski N, Pfeferman A, Carlini EA (1974) Cannabidiol interferes with the effects of delta 9-tetrahydrocannabinol in man. Eur J Pharmacol 28:172–177PubMedGoogle Scholar
  71. Karniol IG, Shirakawa I, Takahashi RN, Knobel E, Musty RE (1975) Effects of delta9-tetrahydrocannabinol and cannabinol in man. Pharmacology 13:502–512PubMedGoogle Scholar
  72. Katona I, Sperlagh B, Magloczky Z, Santha E, Kofalvi A, Czirjak S, Mackie K, Vizi ES, Freund TF (2000) GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus. Neuroscience 100:797–804PubMedGoogle Scholar
  73. Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N, Freund TF (2001) Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 21:9506–9518PubMedGoogle Scholar
  74. Kelly TH, Foltin RW, Rose AJ, Fischman MW, Brady JV (1990) Smoked marijuana effects on tobacco cigarette smoking behavior. J Pharmacol Exp Ther 252:934–944PubMedGoogle Scholar
  75. Lane SD, Cherek DR, Lieving LM, Tcheremissine OV (2005) Marijuana effects on human forgetting functions. J Exp Anal Behav 83:67–83PubMedGoogle Scholar
  76. Lichtman AH (2000) SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats. Eur J Pharmacol 404:175–179PubMedGoogle Scholar
  77. Lichtman AH, Varvel SA, Martin BR (2002) Endocannabinoids in cognition and dependence. Prostaglandins Leukot Essent Fatty Acids 66:269–285PubMedGoogle Scholar
  78. Maccarrone M, Valverde O, Barbaccia ML, Castane A, Maldonado R, Ledent C, Parmentier M, Finazzi-Agro A (2002) Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour. Eur J Neurosci 15:1178–1186PubMedGoogle Scholar
  79. Mailleux P, Vanderhaeghen JJ (1992) Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48:655–668PubMedGoogle Scholar
  80. Mailleux P, Parmentier M, Vanderhaeghen JJ (1992) Distribution of cannabinoid receptor messenger RNA in the human brain: an in situ hybridization histochemistry with oligonucleotides. Neurosci Lett 143:200–204PubMedGoogle Scholar
  81. Margulies JE, Hammer RP Jr (1991) Delta 9-tetrahydrocannabinol alters cerebral metabolism in a biphasic, dose-dependent manner in rat brain. Eur J Pharmacol 202:373–378PubMedGoogle Scholar
  82. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgansberger W, Di Marzo V, Lutz B (2002) The endogenous cannabinoid system controls extinction of aversive memories (see comment). Nature 418:530–534PubMedGoogle Scholar
  83. Martin PD, Shapiro ML (2000) Disparate effects of long-term potentiation on evoked potentials and single CA1 neurons in the hippocampus of anesthetized rats. Hippocampus 10:207–212PubMedGoogle Scholar
  84. Matsuda LA (1997) Molecular aspects of cannabinoid receptors. Crit Rev Neurobiol 11:143–166PubMedGoogle Scholar
  85. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561–564PubMedGoogle Scholar
  86. McGilveray IJ (2005) Pharmacokinetics of cannabinoids. Pain Res Manag 10:15A–22APubMedGoogle Scholar
  87. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83–90PubMedGoogle Scholar
  88. Miller LL, Cornett TL (1978) Marijuana: dose effects on pulse rate, subjective estimates of intoxication, free recall and recognition memory. Pharmacol Biochem Behav 9:573–577PubMedGoogle Scholar
  89. Miller LL, Cornett T, Brightwell D, McFarland D, Drew WG, Wikler A (1976) Marijuana and memory impairment: the effect of retrieval cues on free recall. Pharmacol Biochem Behav 5:639–643PubMedGoogle Scholar
  90. Miller LL, Cornett T, Drew W, McFarland D, Brightwell D, Wikler A (1977a) Marijuana: dose–response effects on pulse rate, subjective estimates of potency, pleasantness, and recognition memory. Pharmacology 15:268–275PubMedCrossRefGoogle Scholar
  91. Miller LL, Cornett TL, Brightwell DR, McFarland DJ, Drew WG, Wikler A (1977b) Marijuana: effects on storage and retrieval of prose material. Psychopharmacology (Berl) 51:311–316Google Scholar
  92. Miller LL, McFarland D, Cornett TL, Brightwell D (1977c) Marijuana and memory impairment: effect on free recall and recognition memory. Pharmacol Biochem Behav 7:99–103PubMedGoogle Scholar
  93. Miller LL, McFarland DJ, Cornett TL, Brightwell DR, Wikler A (1977d) Marijuana: effects on free recall and subjective organization of pictures and words. Psychopharmacology (Berl) 55:257–262Google Scholar
  94. Miller LL, Cornett T, Nallan G (1978) Marijuana: effect on nonverbal free recall as a function of field dependence. Psychopharmacology (Berl) 58:297–301Google Scholar
  95. Miller LL, Cornett TL, Wikler A (1979) Marijuana: effects on pulse rate, subjective estimates of intoxication and multiple measures of memory. Life Sci 25:1325–1330PubMedGoogle Scholar
  96. Misner DL, Sullivan JM (1999) Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. J Neurosci 19:6795–6805PubMedGoogle Scholar
  97. Moscovitch M (1995) Recovered consciousness: a hypothesis concerning modularity and episodic memory. J Clin Exp Neuropsychol 17:276–290PubMedGoogle Scholar
  98. Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61–65PubMedGoogle Scholar
  99. Nava F, Carta G, Colombo G, Gessa GL (2001) Effects of chronic Delta(9)-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze. Neuropharmacology 41:392–399PubMedGoogle Scholar
  100. Nowicky AV, Teyler TJ, Vardaris RM (1987) The modulation of long-term potentiation by delta-9-tetrahydrocannabinol in the rat hippocampus, in vitro. Brain Res Bull 19:663–672PubMedGoogle Scholar
  101. Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK (1980) Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin Pharmacol Ther 28:409–416PubMedCrossRefGoogle Scholar
  102. Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK (1981) Plasma levels of delta 9-tetrahydrocannabinol after intravenous, oral, and smoke administration. NIDA Res Monogr 34:250–256PubMedGoogle Scholar
  103. Owen AM, McMillan KM, Laird AR, Bullmore E (2005) N-back working memory paradigm: a meta-analysis of normative functional neuroimaging studies. Hum Brain Mapp 25:46–59PubMedGoogle Scholar
  104. Pfefferbaum A, Darley CF, Tinklenberg JR, Roth WT, Kopell BS (1977) Marijuana and memory intrusions. J Nerv Ment Dis 165:381–386PubMedGoogle Scholar
  105. Pistis M, Porcu G, Melis M, Diana M, Gessa GL (2001) Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation. Eur J Neurosci 14:96–102PubMedGoogle Scholar
  106. Reibaud M, Obinu MC, Ledent C, Parmentier M, Bohme GA, Imperato A (1999) Enhancement of memory in cannabinoid CB1 receptor knock-out mice. Eur J Pharmacol 379:R1–R2PubMedGoogle Scholar
  107. Rodriguez de Fonseca F, Del Arco I, Bermudez-Silva FJ, Bilbao A, Cippitelli A, Navarro M (2005) The endocannabinoid system: physiology and pharmacology. Alcohol 40:2–14Google Scholar
  108. Shen M, Thayer SA (1999) Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture. Mol Pharmacol 55:8–13PubMedGoogle Scholar
  109. Shen M, Piser TM, Seybold VS, Thayer SA (1996) Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci 16:4322–4334PubMedGoogle Scholar
  110. Spencer KM, Nestor PG, Niznikiewicz MA, Salisbury DF, Shenton ME, McCarley RW (2003) Abnormal neural synchrony in schizophrenia. J Neurosci 23:7407–7411PubMedGoogle Scholar
  111. Squire LR, Alvarez P (1995) Retrograde amnesia and memory consolidation: a neurobiological perspective. Curr Opin Neurobiol 5:169–177PubMedGoogle Scholar
  112. Stella N, Schweitzer P, Piomelli D (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388:773–778PubMedGoogle Scholar
  113. Sternberg S (1966) High-speed scanning in human memory. Science 153:652–654PubMedGoogle Scholar
  114. Stout JC, Murray LL (2001) Assessment of memory in neurogenic communication disorders. Semin Speech Lang 22:137–145PubMedGoogle Scholar
  115. Sullivan JM (1999) Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons. J Neurophysiol 82:1286–1294PubMedGoogle Scholar
  116. Sullivan JM (2000) Cellular and molecular mechanisms underlying learning and memory impairments produced by cannabinoids. Learn Mem 7:132–139PubMedGoogle Scholar
  117. Suzuki A, Josselyn SA, Frankland PW, Masushige S, Silva AJ, Kida S (2004) Memory reconsolidation and extinction have distinct temporal and biochemical signatures. J Neurosci 24:4787–4795PubMedGoogle Scholar
  118. Tanda G, Goldberg SR (2003) Cannabinoids: reward, dependence, and underlying neurochemical mechanisms—a review of recent preclinical data. Psychopharmacology (Berl) 169:115–134Google Scholar
  119. Terranova JP, Michaud JC, Le Fur G, Soubrie P (1995) Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors. Naunyn Schmiedebergs Arch Pharmacol 352:576–579PubMedGoogle Scholar
  120. Terranova JP, Storme JJ, Lafon N, Perio A, Rinaldi-Carmona M, Le Fur G, Soubrie P (1996) Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716. Psychopharmacology 126:165–172PubMedGoogle Scholar
  121. Tinklenberg JR, Melges FT, Hollister LE, Gillespie HK (1970) Marijuana and immediate memory. Nature 226:1171–1172PubMedGoogle Scholar
  122. Tinklenberg JR, Kopell BS, Melges FT, Hollister LE (1972) Marihuana and alcohol, Time production and memory functions. Arch Gen Psychiatry 27:812–815PubMedGoogle Scholar
  123. Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83:393–411PubMedGoogle Scholar
  124. Tulving E (1972) Episodic and semantic memory. Academic Press, New YorkGoogle Scholar
  125. Tulving E, Markowitsch HJ (1998) Episodic and declarative memory: role of the hippocampus. Hippocampus 8:198–204PubMedGoogle Scholar
  126. Turner CE, Elsohly MA, Boeren EG (1980) Constituents of Cannabis sativa L. XVII. A review of the natural constituents. J Nat Prod 43:169–234PubMedGoogle Scholar
  127. Vachon L, Sulkowski A, Rich E (1974) Marihuana effects on learning, attention and time estimation. Psychopharmacologia 39:1–11PubMedGoogle Scholar
  128. Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, Stella N, Makriyannis A, Piomelli D, Davison JS, Marnett LJ, Di Marzo V, Pittman QJ, Patel KD, Sharkey KA (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310:329–332PubMedGoogle Scholar
  129. Varvel SA, Lichtman AH (2002) Evaluation of CB1 receptor knockout mice in the Morris water maze. J Pharmacol Exp Ther 301:915–924PubMedGoogle Scholar
  130. Varvel SA, Anum EA, Lichtman AH (2005) Disruption of CB(1) receptor signaling impairs extinction of spatial memory in mice. Psychopharmacology (Berl) 179:863–872Google Scholar
  131. Wilson RI, Nicoll RA (2002) Endocannabinoid signaling in the brain. Science 296:678–682PubMedGoogle Scholar
  132. Wilson WH, Ellinwood EH, Mathew RJ, Johnson K (1994) Effects of marijuana on performance of a computerized cognitive–neuromotor test battery. Psychiatry Res 51:115–125PubMedGoogle Scholar
  133. Winsauer PJ, Lambert P, Moerschbaecher JM (1999) Cannabinoid ligands and their effects on learning and performance in rhesus monkeys. Behav Pharmacol 10:497–511PubMedCrossRefGoogle Scholar
  134. Witkin HA, Oltman PK (1967) Cognitive style. Int J Neurol 6:119–137Google Scholar
  135. Wolff MC, Leander JD (2003) SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task. Eur J Pharmacol 477:213–217PubMedGoogle Scholar
  136. Zimmerberg B, Glick SD, Jarvik ME (1971) Impairment of recent memory by marihuana and THC in rhesus monkeys. Nature 233:343–345PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Mohini Ranganathan
    • 1
    • 2
    • 3
  • Deepak Cyril D’Souza
    • 1
    • 2
    • 3
    • 4
  1. 1.Schizophrenia Biological Research CenterVA Connecticut Healthcare SystemWest-HavenUSA
  2. 2.Abraham Ribicoff Research FacilitiesConnecticut Mental Health CenterNew HavenUSA
  3. 3.Department of PsychiatryYale University School of MedicineNew HavenUSA
  4. 4.Psychiatry Service, 116AVA Connecticut Healthcare SystemWest HavenUSA

Personalised recommendations